Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe

Vrdoljak, Eduard; Bodoky, Gyorgy; Jassem, Jacek; Popescu, Razvan; Pirker, Robert; Čufer, Tanja; Bešlija, Semir; Eniu, Alexandru; Todorović, Vladimir; Kopečková, Katerina; Kurteva, Galia; Tomašević, Zorica; Sallaku, Agim; Smichkoska, Snezhana; Bajić, Žarko; Sikic, Branimir

doi:10.1634/theoncologist.2018-0093

Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe

Journal

The Oncologist

Date Issued

2019

Author(s)

Vrdoljak, Eduard

Bodoky, Gyorgy

Jassem, Jacek

Popescu, Razvan

Pirker, Robert

Čufer, Tanja

Bešlija, Semir

Eniu, Alexandru

Todorović, Vladimir

Kopečková, Katerina

Kurteva, Galia

Tomašević, Zorica

Sallaku, Agim

Bajić, Žarko

Sikic, Branimir

DOI

10.1634/theoncologist.2018-0093

Abstract

There is a steady decline in cancer mortality in Western Europe (WE), but this trend is not so obvious in Central and Eastern Europe (CEE). One of the largest discrepancies between WE and CEE is the level of investment in cancer care. The objective of our analysis was to examine the correlation between mortality-to-incidence (M/I) ratio and expenditures on oncology drugs in CEE and WE.